PMID- 20170704 OWN - NLM STAT- MEDLINE DCOM- 20100420 LR - 20141120 IS - 1879-3185 (Electronic) IS - 0300-483X (Linking) VI - 270 IP - 2-3 DP - 2010 Apr 11 TI - Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes. PG - 150-7 LID - 10.1016/j.tox.2010.02.010 [doi] AB - 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy), a drug of abuse commonly consumed at rave parties, is often taken in a polydrug abuse scenario, ethanol being one of the most associated drugs. Both MDMA and ethanol are mainly metabolized in the liver with formation of toxic metabolites. Our working hypothesis is that ethanol can modify the metabolism of MDMA through the cytochrome P450 system, and that this effect may be further potentiated by hyperthermia, a well-known consequence of MDMA abuse. To investigate these putative interactions we used primary rat hepatocyte cultures, which were exposed to 300 mM ethanol, 1.6 mM MDMA and the combination of both, at normothermic (36.5 degrees C) and hyperthermic (40.5 degrees C) conditions. After 24 h, the levels of MDA, HMA and HMMA in the cell culture medium were quantified by GC/MS. In addition, we repeated the same experimental design preceded by 1h incubation with 0.18 microM ketoconazole or 150 microM diallyl sulphide (CYP3A and CYP2E1 inhibitors, respectively), to evaluate the putative role of these isoenzymes in the observed effects. The results obtained showed that ethanol exposure increases the formation of some MDMA metabolites such as HMA (1.8 times increase) and MDA (1.5 times increase). This effect was markedly increased under hyperthermic conditions (HMA, MDA and HMMA formation increased 10, 6 and 16 times, respectively) and is mediated, at least partially, by CYP3A and CYP2E1. CI - Copyright 2010 Elsevier Ireland Ltd. All rights reserved. FAU - Pontes, Helena AU - Pontes H AD - REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, Rua Anibal Cunha 164, 4099-030 Porto, Portugal. hpontes@ff.up.pt FAU - de Pinho, Paula Guedes AU - de Pinho PG FAU - Fernandes, Eduarda AU - Fernandes E FAU - Branco, Paula Serio AU - Branco PS FAU - Ferreira, Luisa Maria AU - Ferreira LM FAU - Carmo, Helena AU - Carmo H FAU - Remiao, Fernando AU - Remiao F FAU - Carvalho, Felix AU - Carvalho F FAU - Bastos, Maria Lourdes AU - Bastos ML LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100217 PL - Ireland TA - Toxicology JT - Toxicology JID - 0361055 RN - 0 (Central Nervous System Depressants) RN - 0 (Hallucinogens) RN - 3K9958V90M (Ethanol) RN - 63231-63-0 (RNA) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - EC 1.14.13.- (Cytochrome P-450 CYP2E1) RN - EC 1.14.14.1 (Cytochrome P-450 CYP3A) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Biotransformation MH - Cell Death/drug effects MH - Cell Separation MH - Cells, Cultured MH - Central Nervous System Depressants/*metabolism/*toxicity MH - Cytochrome P-450 CYP2E1/metabolism MH - Cytochrome P-450 CYP3A/metabolism MH - Drug Interactions MH - Ethanol/*metabolism/*toxicity MH - Gas Chromatography-Mass Spectrometry MH - Hallucinogens/*metabolism/*toxicity MH - Hepatocytes/*drug effects/enzymology/*metabolism MH - L-Lactate Dehydrogenase/metabolism MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*metabolism/*toxicity MH - Oxidation-Reduction MH - RNA/biosynthesis/isolation & purification MH - Rats MH - Rats, Wistar MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 2010/02/23 06:00 MHDA- 2010/04/21 06:00 CRDT- 2010/02/23 06:00 PHST- 2009/12/22 00:00 [received] PHST- 2010/02/09 00:00 [revised] PHST- 2010/02/10 00:00 [accepted] PHST- 2010/02/23 06:00 [entrez] PHST- 2010/02/23 06:00 [pubmed] PHST- 2010/04/21 06:00 [medline] AID - S0300-483X(10)00084-3 [pii] AID - 10.1016/j.tox.2010.02.010 [doi] PST - ppublish SO - Toxicology. 2010 Apr 11;270(2-3):150-7. doi: 10.1016/j.tox.2010.02.010. Epub 2010 Feb 17.